Showing 1 - 20 of 48 results
Merit Access Terms and Conditions
By submitting a proposal for Merit Access to ANSTO’s Biosciences, Centre for Accelerator Science, Isotope Tracing, Nuclear Stewardship or the Vivarium capabilities, you are agreeing to the following Terms and Conditions. These Terms and Conditions apply to external merit researchers, scientific collaborators and partners unless there is a specific agreement in place between ANSTO and the home institution of the Principal Investigator.
Scanners to go to a new home after a decade of excellence in preclinical imaging research
Following a decade of imaging to support research and clinical trials at ANSTO and the University of Sydney’s Brain and Mind Centre at Camperdown, two PET scanners have been transferred to the University of Wollongong.
Preclinical imaging
Expertise in the use of PET and SPECT imaging techniques to understand biological processes at the cellular and molecular level. The techniques ae also used to study disease processes and monitor the effects of new therapies
Hungarian Ambassador attends ceremony to mark installation of new imaging scanners
The Hungarian Ambassador to Australia and a small delegation visited ANSTO for a special ceremony to mark the installation and commissioning of two new nuclear medicine scanners from the Hungarian company Mediso Pacific.
Potential true theranostic agent for cancer produced
Scandium 47, a therapeutic radioisotope and potential theranostic, has been produced for the first time at ANSTO. Theranostics are used to both diagnose and treat disease.
User Access
The User Office is the first point of contact for all new and returning facility users accessing ANSTO’s wide range of world-class research infrastructure. These users may be internal ANSTO researchers, external merit researchers, commercial clients, scientific collaborators and partners.
Laboratory Technical Officer, Health Research and Technology Group
Role at ANSTO
Scholarship recipients announced
Four successful applicants announced for the 2018 AINSE-ANSTO-French Embassy Research Internship Program.
Understanding the biological response to radiation
Research is undertaken to characterise and optimise the beneficial impacts of radiation on living matter
Radiotracers
ANSTO provides a range of radiotracers for pre-clinical and clinical research using the OPAL multipurpose reactor. Users can access more than 300 known radiotracers. If a starting material is provided, new and non-commercial radiotracers can be produced.
Radiotracer Methods and Organic Chemistry Task Leader
Role at ANSTO
X-ray Reflectometer
This instrument can measure reflectivity at air-solid or air-liquid interfaces.
Sharing radiochemistry expertise with an IAEA training course
Twenty-four participants from Asia and the Pacific travelled to ANSTO for an International Atomic Energy Agency Regional Training Course on ‘Production and preclinical evaluation of emerging cyclotron-based radiopharmaceuticals’
First synchrotron light is a milestone for new instruments at ANSTO’s Australian Synchrotron
NSTO’S major project to introduce eight new beamlines at the Australian Synchrotron has reached a milestone with the delivery of ‘first light’ to the new MEX-1 beamline.
International award recognises achievement
ANSTO's reactor utilisation team has received an international award.
ARC Linkage grant will use synchrotron techniques to analyse and evaluate innovative battery technology
Radiochemist, NSTLI Biosciences
Role at ANSTO
Funding supports biomedical research
ANSTO part of consortium funded by Federal Government to develop new radioimmunological drugs.
Education Officer
Rochelle Donohue is a dedicated science communicator. She has a Bachelor of Animal and Veterinary Bioscience, as well as a Bachelor of Education (Primary).